A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Podobne knjige/članki

• A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
  od: Chung, C. H., et al.
  Izdano: (2014)
• Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
  od: Kim, Moon Jin, et al.
  Izdano: (2019)
• Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
  od: Huang, Kie Kyon, et al.
  Izdano: (2016)
• Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
  od: J Greenhalgh, et al.
  Izdano: (2009-10-01)
• Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
  od: Hedberg, Matthew L., et al.
  Izdano: (2015)